Q2 2024 EPS Estimates for The Joint Corp. Raised by B. Riley (NASDAQ:JYNT)

The Joint Corp. (NASDAQ:JYNT) – B. Riley increased their Q2 2024 earnings estimates for shares of Joint in a report released on Monday, May 6th. B. Riley analyst J. Van. Sinderen now anticipates that the company will post earnings of ($0.04) per share for the quarter, up from their previous estimate of ($0.05). B. Riley has a “Buy” rating and a $20.00 price objective on the stock. The consensus estimate for Joint’s current full-year earnings is $0.13 per share. B. Riley also issued estimates for Joint’s FY2024 earnings at $0.06 EPS and FY2025 earnings at $0.58 EPS.

Other equities research analysts also recently issued research reports about the company. TheStreet downgraded Joint from a “c-” rating to a “d” rating in a research report on Thursday, March 7th. StockNews.com upgraded Joint from a “hold” rating to a “buy” rating in a report on Monday. Finally, Roth Mkm reissued a “buy” rating and set a $16.00 target price (up previously from $13.00) on shares of Joint in a research report on Friday, May 3rd. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $22.00.

Joint Stock Up 3.5 %

NASDAQ:JYNT opened at $16.48 on Wednesday. Joint has a fifty-two week low of $7.31 and a fifty-two week high of $16.68. The firm’s 50 day moving average is $12.55 and its two-hundred day moving average is $10.35. The company has a market cap of $246.77 million, a P/E ratio of -21.97 and a beta of 1.58.

Joint (NASDAQ:JYNT) last posted its quarterly earnings data on Thursday, March 7th. The company reported $0.07 EPS for the quarter, beating analysts’ consensus estimates of $0.03 by $0.04. Joint had a negative net margin of 9.24% and a positive return on equity of 3.94%. The company had revenue of $30.61 million during the quarter, compared to the consensus estimate of $29.63 million.

Institutional Trading of Joint

Several institutional investors have recently added to or reduced their stakes in the stock. Hudson Bay Capital Management LP bought a new position in Joint during the 3rd quarter worth approximately $867,000. WINTON GROUP Ltd acquired a new position in Joint in the third quarter worth $179,000. First Foundation Advisors acquired a new position in Joint in the third quarter worth $1,336,000. Trexquant Investment LP increased its stake in Joint by 15.2% during the third quarter. Trexquant Investment LP now owns 76,589 shares of the company’s stock valued at $689,000 after purchasing an additional 10,122 shares during the last quarter. Finally, Skylands Capital LLC raised its holdings in shares of Joint by 20.3% during the fourth quarter. Skylands Capital LLC now owns 603,640 shares of the company’s stock worth $5,801,000 after purchasing an additional 101,850 shares during the period. 76.88% of the stock is owned by institutional investors and hedge funds.

About Joint

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.